Log in to save to my catalogue

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in seve...

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in seve...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1017964688

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

About this item

Full title

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2012-04, Vol.379 (9826), p.1613-1620

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Evidence indicates that corticosteroid therapy might be beneficial for the primary treatment of severe Kawasaki disease. We assessed whether addition of prednisolone to intravenous immunoglobulin with aspirin would reduce the incidence of coronary artery abnormalities in patients with severe Kawasaki disease. Methods We did a mul...

Alternative Titles

Full title

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1017964688

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1017964688

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(11)61930-2

How to access this item